Abstract
We report on preparation of potential nucleoside phosphonate prodrugs: 1-{3-hydroxy-2-[O-(adamantylalkyl)phosphorylmethoxy]propyl}cytosines containing two structural fragments providing antiviral activity, nucleoside phosphonate and adamantyl sites.
Similar content being viewed by others
References
De Clercq, E., Adv. Pharmacol., 2013, vol. 67, p. 293. DOI: 10.1016/B978-0-12-405880-4.00008-1.
De Clercq, E., Antiviral Res., 2007, vol. 75, no. 1, p. 1. DOI: 10.1016/j.antiviral.2006.10.006.
De Clercq, E., Biochem. Pharm., 2007, vol. 73, no. 7, p. 911. DOI: 10.1016/j.bcp.2006.09.014.
Holy, A., Antiviral Res., 2006, vol. 71, no. 2–3, p. 248. DOI: 10.1016/j.antiviral.2006.06.002.
De Clercq, E. and Holy, A., Antimicrob. Agents Chemother., 1991, vol. 35, no. 4, p. 701. DOI: 10.1128/AAC.35.4.701.
Schutter, T.D., Andrei, G., Topalis, D., Duraffour, S., Mitera, T., Naesens, L., van den Oord, J., Matthys, P., and Snoeck, R., Cancer Lett., 2013, vol. 329, no. 2, p. 137. DOI: 10.1016/j.canlet. 2012.10.036.
Starrett, J.E.Jr. and Tortolani, D.R., J. Med. Chem., 1994, vol. 37, no. 12, p. 1857. DOI: 10.1021/jm00038a015.
Gerbig, U. and Balzarini, J., Antiviral Res., 2005, vol. 65, no. 3, p. A94. DOI: 10.1016/j.antiviral.2005.01.001.
Gosert, R., Rinaldo, C.H., Wernli, M., Major, E.O., and Hirsch, H.H., Antimicrob. Agents Chemother., 2011, vol. 55, no. 5, p. 2129. DOI: 10.1128/AAC.00046-11.
Cesnek, M., Hockova, D., Holy, A., Dracinsky, M., Baszczynski, O., de Jersey, J., Keough, D.T., and Guddat, L.W., Bioorg. Med. Chem., 2012, vol. 20, no. 2, p. 1076. DOI: 10.1016/j.bmc.2011.11.034.
Pradere, U., Garnier-Amblard, E.C., Coats, S.J., Amblard, F., and Schinazi, R.F., Chem. Rev., 2014, vol. 114, no. 18, p. 9154. DOI: 10.1021/cr5002035.
Gable, J.E., Acker, T.M., and Craik, C.S., Chem. Rev., 2014, vol. 114, no. 22, p. 11382. DOI: 10.1021/cr500255e.
Tichy, T., Andrei, G., Dracinsky, M., Holy, A., Balzarini, J., Snoeck, R., and Krecmerova, M., Bioorg. Med. Chem., 2011, vol. 19, no. 11, p. 3527. DOI: 10.1016/j.bmc.2011.04.016.
Eriksson, U., Peterson, L.W., Kashemirov, B.A., Hilfinger, J.M., Drach, J.C., Borysko, K.Z., Breitenbach, J.M., Kim, J.S., Mitchell, S., Kijek, P., and McKenna, C.E., Mol. Pharmaceutics, 2008, vol. 5, no. 4, p. 598. DOI: 10.1021/mp8000099.
Tollefson, A.E., Spencer, J.F., Ying, B., Buller, R.M.L., Wold, W.S.M., and Toth, K., Antiviral Res., 2014, vol. 112, p. 38. DOI: 10.1016/j.antiviral.2014.10.005.
Ruiz, J., Beadle, J.R., Buller, R.M., Schreiwer, J., Prichard, M.N., Keith, K.A., Lewis, K.C., and Hostetler, K.Y., Bioorg. Med. Chem., 2011, vol. 19, no. 9, p. 2950. DOI: 10.1016/j.bmc. 2011.03.034.
Beadle, J.R., Wan, W.B., Ciesla, S.L., Keith, K.A., Hartline, C., Kern, E.R., and Hostetler, K.Y., J. Med. Chem., 2006, vol. 49, no. 6, p. 2010. DOI: 10.1021/jm050473m.
Hostetler, K.Y., Antiviral Res., 2009, vol. 82, no. 2, p. A84. DOI: 10.1016/j.antiviral.2009.01.005.
Florescu, D.F. and Keek, M., Expert Review of Anti-Infective Therapy, 2014, vol. 12, no. 10, p. 1171. DOI: 10.1586/14787210.2014.948847.
To, K.K.W., Chan, J.F.W., Tsang, A.K.L., Cheng, V.C.C., and Yuen, K.Y., Microbes and Infection, 2014. DOI: 10.1016/j.micinf. 2014.11.007.
Wanka, L., Iqbal, K., and Schreiner, P.R., Chem. Rev., 2013, vol. 113, no. 5, p. 3516. DOI: 10.1021/cr100264t.
Lamoureaux, G. and Artavia, G., Curr. Med. Chem., 2010, vol. 17, no. 26, p. 2967. DOI: 10.2174/092986710792065027.
Klimochkin, Yu., Baimuratov, M., Knyazeva, E., Baleeva, N., Leonova, M., Skomorokhov, M., Belanov, E., Balakhnin, S., Antiviral Res., 2011, vol. 90, no. 2, p. A71. DOI: 10.1016/j.antiviral.2011.03.150.
Moiseev, I.K., Kon’kov, S.A., Ovchinnikov, K.A., Kilyaeva, N.M., Bormasheva, K.M., Nechaeva, O.N., Leonova, M.V., Klimochkin, Yu.N., Balakhnin, S.M., Bormotov, N.I., Serova, O.A., and Belanov, E.F., Pharm. Chem. J., 2012, vol. 45, no. 10, p. 588. DOI: 10.1007/s11094-012-0686-3.
Klimochkin, Yu., Osyanin, V., Golovin, E., Leonova, M., Konkov, S., Kilyaeva, N., Bormotov, N., Serova, O., Balakhnin, S., and Belanov, E., Antiviral Res., 2010, vol. 86, no. 1, p. A59. DOI: 10.1016/j.antiviral.2010.02.447.
Klimochkin, Yu., Osyanin, V., Krasnikov, P., Leonova, M., Golovin, E., Balackhnin, S., and Belanov, E., Antiviral Res., 2009, vol. 82, no. 2, p. A60. DOI: 10.1016/j.antiviral.2009.02.143.
Belanov, E., Leonova, M., Osyanin, V., Krasnikov, P., Kuznetsov, S., Shiryaev, A., Golovin, E., Serova, O., Bormotov, N., Balackhnin, S., and Klimochkin, Yu., Antiviral Res., 2009, vol. 82, no. 2, p. A32. DOI: 10.1016/j.antiviral.2009.02.060.
Reznikov, A.N., Skomorokhov, M.Yu., and Klimochkin, Yu.N., Russ. J. Gen. Chem., 2012, vol. 82, no. 5, p. 835. DOI: 10.1134/S1070363212050052.
Holy, A., Collect. Czech. Chem. Commun., 1979, vol. 44, no. 4, p. 1819. DOI: 10.1135/cccc19791819.
Brodfuehrer, P.R., Howell, H.G., Sapino, Jr.C., and Vemishetti, P., Tetrahedron Lett., 1994, vol. 35, no. 20, p. 3243. DOI: 10.1016/S0040-4039(00)76875-4.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © A.N. Reznikov, M.Yu. Skomorokhov, M.V. Leonova, Yu.N. Klimochkin, 2015, published in Zhurnal Obshchei Khimii, 2015, Vol. 85, No. 2, pp. 229–235.
To the 80th Anniversary of B.I. Ionin
Rights and permissions
About this article
Cite this article
Reznikov, A.N., Skomorokhov, M.Y., Leonova, M.V. et al. Synthesis of adamantyl-containing cidofovir analogs as potential antiviral prodrugs with high bioavailability parameters. Russ J Gen Chem 85, 402–408 (2015). https://doi.org/10.1134/S1070363215020097
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1070363215020097